CSIMarket
 


Scynexis inc   (SCYX)
Other Ticker:  
 

Scynexis Inc 's Quick Ratio

SCYX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




SCYX Quick Ratio (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Current Liabilities Change 171.72 % 255.46 % 140.44 % 2.44 % 1.33 %
Y / Y Cash & cash equivalent Change 198.94 % 166.54 % 92.18 % 4.94 % 6.77 %
Quick Ratio MRQ 5.66 3.69 3.52 3.57 5.14
Overall Ranking # # # # #
Seq. Current Liabilities Change -20.27 % -5.55 % 219.64 % 12.88 % 4.31 %
Seq. Cash & cash equivalent Change 22.21 % -1.11 % 215.46 % -21.59 % 8.97 %



Quick Ratio second quarter 2021 Comment
Scynexis Inc 's Cash & cash equivalent grew by 22.21 % in II. Quarter sequntially, while Current Liabilities decreased, this led to improvement in Scynexis Inc 's Quick Ratio to 5.66, Quick Ratio remained below Scynexis inc average.

Within Major Pharmaceutical Preparations industry 208 other companies have achieved higher Quick Ratio than Scynexis Inc in second quarter 2021. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are SCYX Segments?
See Quick Ratio SCYX on the trailing twelve month basis
Quick Ratio second quarter 2021 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 209
Healthcare Sector # 403
Overall Market # 895


Quick Ratio Statistics
High Average Low
20.74 7.65 0.03
(Sep 30 2015)   (Mar 31 2014)




Financial Statements
Scynexis Inc 's Current Liabilities $ 20 Millions Visit SCYX's Balance sheet
Scynexis Inc 's Cash & cash equivalent $ 112 Millions Visit SCYX's Balance sheet
Source of SCYX's Sales Visit SCYX's Sales by Geography




Companies with similar Quick Ratio in the quarter endingJun 30 2021, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2021 MRQ Cash & cash equivalentJun 30 2021 MRQ Current Liabilities
Diamedica Therapeutics Inc   15.53 $ 21.295  Millions$ 1.371  Millions
Oncorus Inc   14.88 $ 159.920  Millions$ 10.744  Millions
Sio Gene Therapies Inc   14.61 $ 110.976  Millions$ 7.595  Millions
Concert Pharmaceuticals Inc   14.40 $ 124.845  Millions$ 8.670  Millions
Arvinas Inc   14.36 $ 600.576  Millions$ 41.820  Millions
Hoth Therapeutics Inc  14.29 $ 17.428  Millions$ 1.219  Millions
Cyclacel Pharmaceuticals Inc   14.00 $ 43.639  Millions$ 3.118  Millions
Akero Therapeutics inc   13.98 $ 230.028  Millions$ 16.459  Millions
Cellectar Biosciences Inc   13.79 $ 46.778  Millions$ 3.391  Millions
Abcellera Biologics Inc   13.39 $ 792.571  Millions$ 59.190  Millions
Enochian Biosciences Inc  12.97 $ 20.664  Millions$ 1.593  Millions
Repare Therapeutics Inc   12.95 $ 300.795  Millions$ 23.223  Millions
Avadel Pharmaceuticals Plc  12.85 $ 202.843  Millions$ 15.786  Millions
Allogene Therapeutics Inc   12.78 $ 587.707  Millions$ 45.998  Millions
Atreca inc   12.74 $ 182.311  Millions$ 14.307  Millions
Xoma Corporation  12.56 $ 78.945  Millions$ 6.287  Millions
Vanda Pharmaceuticals Inc   12.47 $ 396.493  Millions$ 31.788  Millions
Oramed Pharmaceuticals Inc   12.39 $ 69.641  Millions$ 5.621  Millions
Morphic Holding inc   12.36 $ 431.618  Millions$ 34.912  Millions
Siga Technologies Inc  12.36 $ 98.486  Millions$ 7.971  Millions
Gt Biopharma Inc  12.06 $ 39.505  Millions$ 3.276  Millions
Synlogic Inc   11.99 $ 115.462  Millions$ 9.633  Millions
Cymabay Therapeutics Inc   11.85 $ 106.134  Millions$ 8.959  Millions
Ibio Inc   11.65 $ 77.428  Millions$ 6.645  Millions
Glycomimetics Inc   11.60 $ 118.906  Millions$ 10.249  Millions
Seelos Therapeutics Inc   11.48 $ 87.200  Millions$ 7.595  Millions
Phio Pharmaceuticals Corp   11.41 $ 29.425  Millions$ 2.578  Millions
Marker Therapeutics inc   11.22 $ 57.221  Millions$ 5.101  Millions
Y mabs Therapeutics inc   11.13 $ 233.587  Millions$ 20.986  Millions
Intra cellular Therapies Inc   11.00 $ 554.757  Millions$ 50.422  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HAIN's Profile

Stock Price

HAIN's Financials

Business Description

Fundamentals

Charts & Quotes

HAIN's News

Suppliers

HAIN's Competitors

Customers & Markets

Economic Indicators

HAIN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071